These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 18834432)

  • 21. Beta-cell apoptosis in type 2 diabetes: quantitative and functional consequences.
    Lupi R; Del Prato S
    Diabetes Metab; 2008 Feb; 34 Suppl 2():S56-64. PubMed ID: 18640587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circadian and age-dependent expression patterns of GLUT2 and glucokinase in the pancreatic beta-cell of diabetic and nondiabetic rats.
    Frese T; Bazwinsky I; Mühlbauer E; Peschke E
    Horm Metab Res; 2007 Aug; 39(8):567-74. PubMed ID: 17712721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Androgen receptor: a new player associated with apoptosis and proliferation of pancreatic beta-cell in type 1 diabetes mellitus.
    Li RJ; Qiu SD; Wang HX; Tian H; Wang LR; Huo YW
    Apoptosis; 2008 Aug; 13(8):959-71. PubMed ID: 18543106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Programmed disorders of beta-cell development and function as one cause for type 2 diabetes? The GK rat paradigm.
    Portha B
    Diabetes Metab Res Rev; 2005; 21(6):495-504. PubMed ID: 15926190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A general and islet cell-enriched overexpression of IGF-I results in normal islet cell growth, hypoglycemia, and significant resistance to experimental diabetes.
    Robertson K; Lu Y; De Jesus K; Li B; Su Q; Lund PK; Liu JL
    Am J Physiol Endocrinol Metab; 2008 May; 294(5):E928-38. PubMed ID: 18270301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of chronic rosiglitazone, metformin and glyburide treatment on beta-cell mass, function and insulin sensitivity in mZDF rats.
    Atkinson LL; McDonald-Dyck C; Benkoczi C; Finegood DT
    Diabetes Obes Metab; 2008 Sep; 10(9):780-90. PubMed ID: 17970758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta-cell growth in the neonatal Goto-Kakisaki rat and regeneration after treatment with streptozotocin at birth.
    Movassat J; Portha B
    Diabetologia; 1999 Sep; 42(9):1098-106. PubMed ID: 10447522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants of pancreatic beta-cell regeneration.
    Khalaileh A; Gonen-Gross T; Magenheim J; Nir T; Porat S; Salpeter S; Stolovich-Rain M; Swisa A; Weinberg N; Dor Y
    Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():128-35. PubMed ID: 18834440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effect of berberine on beta cells in streptozotocin- and high-carbohydrate/high-fat diet-induced diabetic rats.
    Zhou J; Zhou S; Tang J; Zhang K; Guang L; Huang Y; Xu Y; Ying Y; Zhang L; Li D
    Eur J Pharmacol; 2009 Mar; 606(1-3):262-8. PubMed ID: 19374872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreatic beta-cell hyperactivity in morbidly obese adolescents.
    Mercado AB; Castells S
    Pediatr Endocrinol Rev; 2006 Dec; 3 Suppl 4():560-3. PubMed ID: 17237743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fate of the beta-cell in the pathophysiology of type 2 diabetes.
    Campbell RK
    J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S10-5. PubMed ID: 19801360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective effect of testosterone on early apoptotic damage induced by streptozotocin in rat pancreas.
    Morimoto S; Mendoza-Rodríguez CA; Hiriart M; Larrieta ME; Vital P; Cerbón MA
    J Endocrinol; 2005 Nov; 187(2):217-24. PubMed ID: 16293769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The GK rat beta-cell: a prototype for the diseased human beta-cell in type 2 diabetes?
    Portha B; Lacraz G; Kergoat M; Homo-Delarche F; Giroix MH; Bailbé D; Gangnerau MN; Dolz M; Tourrel-Cuzin C; Movassat J
    Mol Cell Endocrinol; 2009 Jan; 297(1-2):73-85. PubMed ID: 18640239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recovery from diabetes in mice by beta cell regeneration.
    Nir T; Melton DA; Dor Y
    J Clin Invest; 2007 Sep; 117(9):2553-61. PubMed ID: 17786244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dominant-negative effects of a novel mutated Ins2 allele causes early-onset diabetes and severe beta-cell loss in Munich Ins2C95S mutant mice.
    Herbach N; Rathkolb B; Kemter E; Pichl L; Klaften M; de Angelis MH; Halban PA; Wolf E; Aigner B; Wanke R
    Diabetes; 2007 May; 56(5):1268-76. PubMed ID: 17303807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of nicotinamide on experimental induced diabetes.
    Alenzi FQ
    Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):11-8. PubMed ID: 19279354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recovery from diabetes in neonatal mice after a low-dose streptozotocin treatment.
    Kataoka M; Kawamuro Y; Shiraki N; Miki R; Sakano D; Yoshida T; Yasukawa T; Kume K; Kume S
    Biochem Biophys Res Commun; 2013 Jan; 430(3):1103-8. PubMed ID: 23257160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective effect of caffeine on streptozotocin-induced beta-cell damage in rats.
    Kagami K; Morita H; Onda K; Hirano T; Oka K
    J Pharm Pharmacol; 2008 Sep; 60(9):1161-5. PubMed ID: 18718119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Islet neogenesis associated protein transgenic mice are resistant to hyperglycemia induced by streptozotocin.
    Taylor-Fishwick DA; Bowman A; Hamblet N; Bernard P; Harlan DM; Vinik AI
    J Endocrinol; 2006 Sep; 190(3):729-37. PubMed ID: 17003274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydrangea dulcis folium preserves beta-cell mass in diabetic db/db mice.
    Kim MJ; Leem KH; Kim HK
    Food Chem Toxicol; 2009 Jul; 47(7):1685-8. PubMed ID: 19394398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.